Dioxin may promote inflammation-related development of endometriosis

Fertility and Sterility

Volumn 89, Issue 5 SUPPL., 2008, Pages 1287-1298

  Bruner Tran, Kaylon L ^a   Yeaman, Grant R ^a   Crispens, Marta A ^a   Igarashi, Toshio M ^a   Osteen, Kevin G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dioxin; Endometriosis; inflammation; leukocytes; progesterone

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CHAPERONE; DIBENZOFURAN DERIVATIVE; DIOXIN; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN; HYPOXIA INDUCIBLE FACTOR 1BETA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; MATRILYSIN; POLYCHLORINATED DIBENZODIOXIN; PROGESTERONE; PROGESTERONE RECEPTOR B; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA2;

CHEMICAL STRUCTURE; DEGRADATION KINETICS; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HORMONAL REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIGAND BINDING; MENSTRUAL CYCLE; NEUTROPHIL; NONHUMAN; OVARIECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICOKINETICS;

ANIMALS; DIOXINS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL;

EID: 43549095903     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.102     Document Type: Review

References (127)

1. Rier S.E., Martin D.C., Bowman R.E., Dmowski W.P., and Becker J.L. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 21 (1993) 433-441
2. Fierens S., Mairesse H., Heilier J.F., De Burbure C., Focant J.F., Eppe G., et al. Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8 (2003) 529-534
3. Heilier J.F., Nackers F., Verougstraete V., Tonglet R., Lison D., and Donnez J. Increased dioxin-like compounds in the serum of women with peritoneal endometriosis and deep endometriotic (adenomyotic) nodules. Fertil Steril 84 (2005) 305-312
4. Pauwels A., Schepens P.J., D'Hooghe T., Delbeke L., Dhont M., Brouwer A., et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum Reprod 16 (2001) 2050-2055
5. Porpora M.G., Ingelido A.M., di Domenico A., Ferro A., Crobu M., Pallante D., et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis. Chemosphere 63 (2006) 1361-1367
6. Koninckx P.R. The physiopathology of endometriosis: pollution and dioxin. Gynecol Obstet Invest 47 Suppl 1 (1999) 47-49 50
7. Boyd J, Clark G, Walmer D, Patterson D, Needham L, Lucier G. Endometriosis and the environment: biomarkers of toxin exposure [abstract]. Presented at Endometriosis 2000, May 15-17, 1995, Bethesda, MD.
8. Lebel G., Dodin S., Ayotte P., Marcoux S., Ferron L.A., and Dewailly E. Organochlorine exposure and the risk of endometriosis. Fertil Steril 69 (1998) 221-228
9. Guo S.W. The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest 57 (2004) 157-173
10. Heilier JF, Donnez J, Lison D. Organochlorines and endometriosis: a mini-review. Chemosphere. Published online November 13, 2007.
11. Newbold R.R. Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol Appl Pharmacol 199 (2004) 142-150
12. Rubin M.M. Antenatal exposure to DES: lessons learned... future concerns. Obstet Gynecol Surv 62 (2007) 548-555
13. Heindel J.J., McAllister K.A., Worth Jr. L., and Tyson F.L. Environmental epigenomics, imprinting and disease susceptibility. Epigenetics 1 (2006) 1-6
14. Hombach-Klonisch S., Pocar P., Kietz S., and Klonisch T. Molecular actions of polyhalogenated arylhydrocarbons (PAHs) in female reproduction. Curr Med Chem 12 (2005) 599-616
15. Birnbaum L.S., and Tuomisto J. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17 (2000) 275-288
16. Birnbaum L.S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect 102 Suppl 9 (1994) 157-167
17. Harrad S., Wang Y., Sandaradura S., and Leeds A. Human dietary intake and excretion of dioxin-like compounds. J Environ Monit 5 (2003) 224-228
18. Pompa G., Caloni F., and Fracchiolla M.L. Dioxin and PCB contamination of fish and shellfish: assessment of human exposure. Review of the international situation. Vet Res Commun 27 Suppl 1 (2003) 159-167
19. Schecter A., Wallace D., Pavuk M., Piskac A., and Papke O. Dioxins in commercial United States baby food. J Toxicol Environ Health A 65 (2002) 1937-1943
20. Van den Berg M., Birnbaum L., Bosveld A.T., Brunström B., Cook P., Feeley M., et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106 (1998) 775-792
21. Hamm J.T., Chen C.Y., and Birnbaum L.S. A mixture of dioxins, furans, and non-ortho PCBs based upon consensus toxic equivalency factors produces dioxin-like reproductive effects. Toxicol Sci 74 (2003) 182-191
22. Chen C.Y., Hamm J.T., Hass J.R., and Birnbaum L.S. Disposition of polychlorinated dibenzo-p-dioxins, dibenzofurans, and non-ortho polychlorinated biphenyls in pregnant long evans rats and the transfer to offspring. Toxicol Appl Pharmacol 173 (2001) 65-88
23. Heimler I., Rawlins R.G., Owen H., and Hutz R.J. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of human luteinized granulosa cells. Endocrinology 139 (1998) 4373-4379
24. Moran F.M., VandeVoort C.A., Overstreet J.W., Lasley B.L., and Conley A.J. Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17α-hydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology 144 (2003) 467-473
25. Pocar P., Fischer B., Klonisch T., and Hombach-Klonisch S. Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction. Reproduction 129 (2005) 379-389
26. Pande K., Moran S.M., and Bradfield C.A. Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines. Mol Pharmacol 67 (2005) 1393-1398
27. Shi Y.L., Luo X.Z., Zhu X.Y., Hua K.Q., Zhu Y., and Li D.J. Effects of combined 17β-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture. Hum Reprod 21 (2006) 870-879
28. Zhao D., Pritts E.A., Chao V.A., Savouret J.F., and Taylor R.N. Dioxin stimulates RANTES expression in an in-vitro model of endometriosis. Mol Hum Reprod 8 (2002) 849-854
29. Osteen K.G., Bruner-Tran K.L., and Eisenberg E. Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis. Fertil Steril 83 (2005) 529-537
30. Igarashi T.M., Bruner-Tran K.L., Yeaman G.R., Lessey B.A., Edwards D.P., Eisenberg E., et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril 84 (2005) 67-74
31. Bruner K.L., Rodgers W.H., Gold L.I., Korc M., Hargrove J.T., Matrisian L.M., et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92 (1995) 7362-7366
32. Keller N.R., Sierra-Rivera E., Eisenberg E., and Osteen K.G. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1α in human endometrial stromal cells. J Clin Endocrinol Metabol 85 (2000) 1611-1619
33. Osteen K.G., Yeaman G.R., and Bruner-Tran K.L. Matrix metalloproteinases and endometriosis. Sem Reprod Med 21 (2003) 155-164
34. Bruner-Tran K.L., Zhang Z., Eisenberg E., Winneker R.C., and Osteen K.G. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J Clin Endocrinol Metabol 91 (2006) 1554-1560
35. Gorivodsky M., Torchinsky A., Zemliak I., Savion S., Fein A., and Toder V. TGF β 2 mRNA expression and pregnancy failure in mice. Am J Reprod Immunol 42 (1999) 124-133
36. Simpson H., Robson S.C., Bulmer J.N., Barber A., and Lyall F. Transforming growth factor beta expression in human placenta and placental bed during early pregnancy. Placenta 23 (2002) 44-58
37. Clark D.A., and Croitoru K. TH1/TH2,3 imbalance due to cytokine-producing NK, gamma-delta T and NK-gamma-delta T cells in murine pregnancy decidua in success or failure of pregnancy. Am J Reprod Immunol 45 (2001) 257-265
38. Bruner-Tran KL, Yeaman GR, Eisenberg E, Osteen KG. Developmental dioxin exposure in mice alters uterine DNA methylation patterns and protein expression in Adult animals and leads to an endometriosis-like phenotype. Presented at the 63rd annual meeting of the American Society for Reproductive Medicine, October 21-25, 2007, Washington, D.C.
39. Fenaux J.B., Gogal Jr. R.M., and Ahmed S.A. Diethylstilbestrol exposure during fetal development affects thymus: studies in fourteen-month-old mice. J Reprod Immunol 64 (2004) 75-90
40. Prins G.S., Birch L., Tang W.Y., and Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 23 (2007) 374-382
41. Nayyar T., Bruner-Tran K.L., Piestrzeniewicz-Ulanska D., and Osteen K.G. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 23 (2007) 326-336
42. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metabol 85 (2000) 2897-2902
43. Bulun S.E., Cheng Y.H., Yin P., Imir G., Utsunomiya H., Attar E., et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248 (2006) 94-103
44. McNulty W.P. Toxicity and fetotoxicity of TCDD, TCDF and PCB isomers in rhesus macaques (Macaca mulatta). Environ Health Perspect 60 (1985) 77-88
45. Tibbetts T.A., Conneely O.M., and O'Malley B.W. Progesterone via its receptor antagonizes the proinflammatory activity of estrogen in the mouse uterus. Biol Reprod 60 (1999) 1158-1165
46. Majewski A.C., and Hansen P.J. Progesterone inhibits rejection of xenogeneic transplants in the sheep uterus. Horm Res 58 (2002) 128-135
47. Mendelson C.R., and Hardy D.B. Role of the progesterone receptor (PR) in the regulation of inflammatory response pathways and aromatase in the breast. J Steroid Biochem Mol Biol 102 (2006) 241-249
48. Braun D.P., and Dmowski W.P. Endometriosis: abnormal endometrium and dysfunctional immune response. Curr Opin Obstet Gynecol 10 (1998) 365-369
49. Gleicher N., el-Roeiy A., Confino E., and Friberg J. Is endometriosis an autoimmune disease?. Obstet Gynecol 70 (1987) 115-122
50. Iborra A., Palacio J.R., Ulcova-Gallova Z., and Martinez P. Autoimmune response in women with endometriosis. Am J Reprod Immunol 44 (2000) 236-241
51. Maeda N., Izumiya C., Oguri H., Kusume T., Yamamoto Y., and Fukaya T. Aberrant expression of intercellular adhesion molecule-1 and killer inhibitory receptors induces immune tolerance in women with pelvic endometriosis. Fertil Steril 77 (2002) 679-683
52. Matarese G., De Placido G., Nikas Y., and Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 9 (2003) 223-228
53. Nothnick W.B. Treating endometriosis as an autoimmune disease. Fertil Steril 76 (2001) 223-231
54. Rier S.E., and Yeaman G.R. Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Semin Reprod Endocrinol 15 (1997) 209-220
55. Sidell N., Han S.W., and Parthasarathy S. Regulation and modulation of abnormal immune responses in endometriosis. Ann NY Acad Sci 955 (2002) 159-173 99-200;396-406
56. Yeaman G.R., Collins J.E., and Lang G.A. Autoantibody responses to carbohydrate epitopes in endometriosis. Ann NY Acad Sci 955 (2002) 174-182 199-200, 396-406
57. Bruner-Tran K.L., Eisenberg E., Yeaman G.R., Anderson T.A., McBean J., and Osteen K.G. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metabol 87 (2002) 4782-4791
58. Kao L.C., Germeyer A., Tulac S., Lobo S., Yang J.P., Taylor R.N., et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144 (2003) 2870-2881
59. Yeaman G.R., Collins J.E., Fanger M.W., Wira C.R., and Lydyard P.M. CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 102 (2001) 434-440
60. Rodgers W.H., Osteen K.G., Matrisian L.M., Navre M., Giudice L.C., and Gorstein F. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168 (1993) 253-260
61. Rodgers W.H., Matrisian L.M., Giudice L.C., Dsupin B., Cannon P., Svitek C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94 (1994) 946-953
62. Salamonsen L.A., Zhang J., and Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol 57 (2002) 95-108
63. Givan A.L., White H.D., Stern J.E., Colby E., Gosselin E.J., Guyre P.M., et al. Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 38 (1997) 350-359
64. Hannan N.J., and Salamonsen L.A. Role of chemokines in the endometrium and in embryo implantation. Curr Opin Obstet Gynecol 19 (2007) 266-272
65. King A., and Loke Y.W. Uterine large granular lymphocytes: a possible role in embryonic implantation?. Am J Obstet Gynecol 162 (1990) 308-310
66. Wira C.R., Fahey J.V., White H.D., Yeaman G.R., Givan A.L., and Howell A.L. The mucosal immune system in the human female reproductive tract: influence of stage of the menstrual cycle and menopause on mucosal immunity in the uterus. In: Glasser S.R., Aplin J., Giudice L., and Tabibzadeh S. (Eds). The endometrium (2002), Harwood Academic, Reading, UK 359-391
67. Yeaman G.R., Guyre P.M., Fanger M.W., Collins J.E., White H.D., Rathbun W., et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 61 (1997) 427-435
68. Teske S., Bohn A.A., Regal J.F., Neumiller J.J., and Lawrence B.P. Activation of the aryl hydrocarbon receptor increases pulmonary neutrophilia and diminishes host resistance to influenza A virus. Am J Physiol Lung Cell Mol Physiol 289 (2005) L111-L124
69. Vogel C.F., Nishimura N., Sciullo E., Wong P., Li W., and Matsumura F. Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Arch Biochem Biophys 461 (2007) 169-175
70. Curry Jr. T.E., and Osteen K.G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24 (2003) 428-465
71. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279 (2004) 23847-23850
72. Uno S., Dalton T.P., Derkenne S., Curran C.P., Miller M.L., Shertzer H.G., and Nebert D.W. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 65 (2004) 1225-1237
73. Bofinger D.P., Feng L., Chi L.H., Love J., Stephen F.D., Sutter T.R., et al. Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium. Toxicol Sci 62 (2001) 299-314
74. Igarashi T., Osuga U., Tsutsumi O., Momoeda M., Ando K., Matsumi H., et al. Expression of Ah receptor and dioxin-related genes in human uterine endometrium in women with or without endometriosis. Endocr J 46 (1999) 765-772
75. Kuchenhoff A., Seliger G., Klonisch T., Tscheudschilsuren G., Kaltwasser P., Seliger E., et al. Arylhydrocarbon receptor expression in the human endometrium. Fertil Steril 71 (1999) 354-360
76. Abrahams V.M., Collins J.E., Wira C.R., Fanger M.W., and Yeaman G.R. Inhibition of human polymorphonuclear cell oxidative burst by 17-beta-estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Reprod Immunol 50 (2003) 463-472
77. Doi H., Baba T., Tohyama C., and Nohara K. Functional activation of arylhydrocarbon receptor (AhR) in primary T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemosphere 52 (2003) 655-662
78. Laupeze B., Amiot L., Sparfel L., Le Ferrec E., Fauchet R., and Fardel O. Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells. J Immunol 168 (2002) 2652-2658
79. van Grevenynghe J., Rion S., Le Ferrec E., Le Vee M., Amiot L., Fauchet R., et al. Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages. J Immunol 170 (2003) 2374-2381
80. Poellinger L. Mechanistic aspects-the dioxin (aryl hydrocarbon) receptor. Food Addit Contam 17 (2000) 261-266
81. Yang J.H. Expression of dioxin-responsive genes in human endometrial cells in culture. Biochem Biophys Res Commun 257 (1999) 259-263
82. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 141 (2002) 41-61
83. Abrahams V.M., Collins J.E., and Yeaman G.R. The effects of dioxin on estradiol modulation of oxidative burst metabolism by human polymorphonuclear leucocytes. Organohalogen Compounds 49 (2000) 377-380
84. McMillan B.J., and Bradfield C.A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol Pharmacol 72 (2007) 487-498
85. Bruner-Tran K.L., Rier S.E., Eisenberg E., and Osteen K.G. The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecol Obstet Invest 48 Suppl 1 (1999) 45-56
86. Osteen K.G., Keller N.R., Feltus F.A., and Melner M.H. Paracrine regulation of matrix metalloproteinase expression in the normal human endometrium. Gynecol Obstet Invest 48 Suppl 1 (1999) 2-13
87. Holsapple M.P., Karras J.G., Ledbetter J.A., Schieven G.L., Burchiel S.W., Davila D.R., et al. Molecular mechanisms of toxicant-induced immunosuppression: role of second messengers. Annu Rev Pharmacol Toxicol 36 (1996) 131-159
88. Tian Y., Rabson A.B., and Gallo M.A. Ah receptor and NF-κB interactions: mechanisms and physiological implications. Chem Biol Interact 141 (2002) 97-115
89. Cao W.G., Morin M., Metz C., Maheux R., and Akoum A. Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NF-κB. Biol Reprod 73 (2005) 565-570
90. González-Ramos R., Donnez J., Defrère S., Leclercq I., Squifflet J., Lousse J.C., and Van Langendonckt A. Nuclear factor-κB is constitutively activated in peritoneal endometriosis. Mol Hum Reprod 13 (2007) 503-509
91. Guo S.W. Nuclear factor-κb (NF-κB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?. Gynecol Obstetric Invest 63 (2007) 71-97
92. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-κB: its role in health and disease. J Mol Med 82 (2004) 434-448
93. Neumann M., and Naumann M. Beyond IκBs: alternative regulation of NF-κB activity. FASEB J 21 (2007) 2642-2654
94. Wilkinson K.D. Signal transduction: aspirin, ubiquitin and cancer. Nature 424 (2003) 738-739
95. Finco T.S., and Baldwin A.S. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3 (1995) 263-272
96. Baldi L., Brown K., Franzoso G., and Siebenlist U. Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I κB-α. J Biol Chem 271 (1996) 376-379
97. Roff M., Thompson J., Rodriguez M.S., Jacque J.M., Baleux F., Arenzana-Seisdedos F., and Hay R.T. Role of IκB alpha ubiquitination in signal-induced activation of NF-κB in vivo. J Biol Chem 271 (1996) 7844-7850
98. King A.E., Critchley H.O., and Kelly R.W. The NF-κB pathway in human endometrium and first trimester decidua. Mol Hum Reprod 7 (2001) 175-183
99. Laird S.M., Tuckerman E.M., Cork B.A., and Li T.C. Expression of nuclear factor kappa B in human endometrium; role in the control of interleukin 6 and leukaemia inhibitory factor production. Mol Hum Reprod 6 (2000) 34-40
100. Page M., Tuckerman E.M., Li T.C., and Laird S.M. Expression of nuclear factor kappa B components in human endometrium. J Reprod Immunol 54 (2002) 1-13
101. Ruby C.E., Leid M., and Kerkvliet N.I. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-κB/Rel in dendritic cells: p50 homodimer activation is not affected. Mol Pharmacol 62 (2002) 722-728
102. Thatcher T.H., Maggirwar S.B., Baglole C.J., Lakatos H.F., Gasiewicz T.A., Phipps R.P., et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-κB component RelB. Am J Pathol 170 (2007) 855-864
103. Tian Y., Ke S., Denison M.S., Rabson A.B., and Gallo M.A. . Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274 (1999) 510-515
104. Singh N.P., Nagarkatti M., and Nagarkatti P.S. Role of dioxin response element and nuclear factor-κB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol Pharmacol 71 (2007) 145-157
105. Camacho I.A., Singh N., Hegde V.L., Nagarkatti M., and Nagarkatti P.S. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-κB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175 (2005) 90-103
106. Buchanan D.L., Sato T., Peterson R.E., and Cooke P.S. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse uterus: critical role of the aryl hydrocarbon receptor in stromal tissue. Toxicol Sci 57 (2000) 302-311
107. Wang F., He Y.L., Peng D.X., and Liu M.B. Expressions of nuclear factor-κB and intercellular adhesion molecule-1 in endometriosis. [article in Chinese]. Di Yi Jun Yi Da Xue Xue Bao 25 (2005) 703-705
108. Lebovic D.I., Chao V.A., Martini J.F., and Taylor R.N. IL-1β induction of RANTES (regulated upon activation, normal T cell expressed and secreted) chemokine gene expression in endometriotic stromal cells depends on a nuclear factor-κB site in the proximal promoter. J Clini Endocrinol Metabol 86 (2001) 4759-4764
109. Yamauchi N., Harada T., Taniguchi F., Yoshida S., Iwabe T., and Terakawa N. Tumor necrosis factor-α induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-κB and mitogen-activated protein kinase pathways. Fertil Steril 82 Suppl 3 (2004) 1023-1028
110. Wieser F., Vigne J.L., Ryan I., Hornung D., Djalali S., and Taylor R.N. Sulindac suppresses nuclear factor-κB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metabol 90 (2005) 6441-6447
111. Lydon J.P., DeMayo F.J., Conneely O.M., and O'Malley B.W. Reproductive phenotypes of the progesterone receptor null mutant mouse. J Steroid Bochem Mol Biol 56 (1996) 67-77
112. Bruner K.L., Matrisian L.M., Rodgers W.H., Gorstein F., and Osteen K.G. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99 (1997) 2851-2857
113. Bruner-Tran KL, Gladson S, Higginbotham JN, Eisenberg E, Yeaman GR, Osteen KG. Experimental endometriosis in immune compromised mice following adoptive transfer of human immune cells. In: 62nd Annual Meeting of the American Society for Reproductive Medicine, October 21-25, 2006; New Orleans, Louisiana.
114. Hansen S., Sorensen F.B., Vach W., Grabau D.A., Bak M., and Rose C. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients. Histopathology 44 (2004) 428-436
115. McCarthy N.J., Yang X., Linnoila I.R., Merino M.J., Hewitt S.M., Parr A.L., et al. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer. Clin Cancer Res 8 (2002) 3857-3862
116. Salvesen H.B., Gulluoglu M.G., Stefansson I., and Akslen L.A. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 111 (2003) 1011-1018
117. Kim S.H., Choi Y.M., Chae H.D., Kim K.R., Kim C.H., and Kang B.M. Increased expression of endoglin in the eutopic endometrium of women with endometriosis. Fertil Steril 76 (2001) 918-922
118. Ancelin M., Buteau-Lozano H., Meduri G., Osborne-Pellegrin M., Sordello S., Plouet J., et al. A dynamic shift of VEGF isoforms with a transient and selective progesterone-induced expression of VEGF189 regulates angiogenesis and vascular permeability in human uterus. Proc Natl Acad Sci USA 99 (2002) 6023-6028
119. Ancelin M., Chollet-Martin S., Herve M.A., Legrand C., El Benna J., and Perrot-Applanat M. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest 84 (2004) 502-512
120. Gargett C.E., and Rogers P.A. Human endometrial angiogenesis. Reproduction 121 (2001) 181-186
121. Mueller M.D., Lebovic D.I., Garrett E., and Taylor R.N. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 74 (2000) 107-112
122. Nozawa H., Chiu C., and Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 103 (2006) 12493-12498
123. Tee M.K., Vigne J.L., and Taylor R.N. All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology 147 (2006) 1264-1270
124. Hull L.M., Charnock-Jones D.S., Chan C.L.K., Bruner K.L., Osteen K.G., Tom B.D.M., et al. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metabol 88 (2003) 2889-2899
125. Bruner K.L., Eisenberg E., Gorstein F., and Osteen K.G. Progesterone and transforming growth factor-beta coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis. Steroids 64 (1999) 648-653
126. Bruner-Tran K.L., Webster-Clair D., and Osteen K.G. Experimental endometriosis: the nude mouse as a xenographic host. Ann NY Acad Sci 955 (2002) 328-339 340-2;396-406
127. Greenberg L.H., and Slayden O.D. Human endometriotic xenografts in immunodeficient RAG-2/gamma(c)KO mice. Am J Obstet Gynecol 190 (2004) 1788-1795 1795-6